BHF vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a low P/E of 4.52 and a Price/Book of 0.58 suggesting potential value, the company faces declining revenue (YoY -10.10%) and erratic earnings performance, including large negative surprises. Strong operating margins and ROE of 16.18% are offset by high debt/equity of 1.47 and extremely weak technical and dividend signals. Analysts consensus is a hold, but the stock trades above the conservative Graham Number of $188.54, raising valuation concerns.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BHF vs BRK-B: Head-to-Head Comparison
This page compares Brighthouse Financial, Inc. (BHF) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.